Abbonarsi

Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V - 14/12/17

Doi : 10.1016/j.jaad.2016.12.020 
Daniel Walker, MD a, Joseph S. Susa, DO b, Sharif Currimbhoy, MD b, Heidi Jacobe, MD, MSCS b,
a Department of Dermatology, University of Arkansas, Fayetteville, Arkansas 
b Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 

Correspondence to: Heidi Jacobe, MD, MSCS, Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas 75390-9069, TX.Department of DermatologyUniversity of Texas Southwestern Medical Center5323 Harry Hines BlvdDallasTX75390-9069

Abstract

Background

Histopathological features in morphea (localized scleroderma) and their clinical correlates are poorly described.

Objective

We sought to systematically describe histologic changes of morphea in a large, well-annotated cohort and determine the association between histopathology and clinical features.

Methods

This was a cross-sectional study of 83 patients enrolled in the Morphea in Adults and Children cohort. The main outcome measure was the association of microanatomical location and degree of sclerosis and inflammation seen on histologic samples with patient-reported symptoms and physician-based measures of severity.

Results

Pattern of sclerosis was associated with morphea subtype, the presence of patient-reported symptoms, and functional limitation. A bottom-heavy pattern of sclerosis was associated with pain and tightness (P = .0039 and .001, respectively). These symptoms were not associated with a top-heavy pattern. Severe inflammation may be associated with pain and functional limitation (P = .073 for both).

Limitations

Small sample size limits ability to detect associations, particularly in subgroups.

Conclusions

Histopathological examination of morphea may assist in identifying patients who may require additional monitoring and treatment. Features such as patterns of sclerosis and severity of inflammation should be included in pathology reports to help aid in clinical management.

Il testo completo di questo articolo è disponibile in PDF.

Key words : morphea, pain, pathology, sclerosis, severity, symptoms


Mappa


 This work was conducted with support from UT-STAR, National Institutes of Health (NIH)/National Center for Research Resources (NCRR)/National Center for Advancing Translational Sciences grant number UL1RR024982. The content is solely the responsibility of the authors and does not necessarily represent the official views of University of Texas Science Teacher Access to Resources at Southwestern (UT-STAR), University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centers, NCRR, or NIH. Research for this manuscript was supported in part by NIH grant number K23AR056303-4.
 Conflicts of interest: None declared.
 Reprints not available from the authors.


© 2016  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 76 - N° 6

P. 1124-1130 - giugno 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Nail involvement in systemic sclerosis
  • Isabelle Marie, Vincent Gremain, Kladoum Nassermadji, Laetitia Richard, Pascal Joly, Jean-François Menard, Hervé Levesque
| Articolo seguente Articolo seguente
  • Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria
  • Sarah E. Stuart, Patrick Schoen, Chengshi Jin, Rupa Parvataneni, Sarah Arron, Eleni Linos, W. John Boscardin, Mary-Margaret Chren

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.